The AI era has moved from potential to proof. In 2026, the products that matter are not the most complex; they are the ones delivering meas...

British drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...

Elon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...

Originally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...

The Supreme Court has ruled that accused individuals must have access to chargesheet documents. Withholding these materials can severely im...

India's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...

Walmart investors on Thursday voted against a shareholder proposal asking it to report on how its use of AI is affecting the well-being of ...

Eastern Congo faces a rapid Ebola outbreak. Women are primary caregivers, increasing their infection risk. Many lack protective gear, forci...

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...

CEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...

Fish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diab...

Wockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...

Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...

A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...

Heads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...

Wockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...